Brugada syndrome with atypical ECG: Downsloping ST-segment elevation in inferior leads

Journal of Electrocardiology

Volumn 37, Issue 2, 2004, Pages 101-104

  Pérez Riera, Andrés Ricardo ^a,d   Ferreira, Celso ^a   Schapachnik, Edgardo ^b   Sanches, Paulo Cesar ^c   Moffa, Paulo Jorge ^c  

^a Nursing School at ABC Foundation   (Brazil)

^b Acute General Hospital   (Argentina)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Univ of Sao Paulo's Sch of Med ^*  (Brazil)

Author keywords

Atypical Brugada Syndrome; Downsloping ST segment elevation in inferior leads

Indexed keywords

NITRATE;

ADULT; ARTICLE; ASYSTOLE; BRUGADA SYNDROME; CASE REPORT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHIC LEAD; ELECTROCARDIOGRAPHY MONITORING; ELECTROLYTE DISTURBANCE; EXTRASYSTOLE; FAMILY LIFE; GENETIC ANALYSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYPOTHERMIA; IDIOPATHIC DISEASE; IMMIGRANT; MALE; PRIORITY JOURNAL; RELATIVE; ST SEGMENT ELEVATION; SUDDEN DEATH; SUDDEN UNEXPLAINED DEATH SYNDROME; SYMPTOMATOLOGY; SYNCOPE; THAILAND; THORAX RADIOGRAPHY;

EID: 2442705404     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2004.01.002     Document Type: Article

References (25)

1. Wilde AA, Antzelevitch C, Borggrefe M, et al: Study Group on the Molecular Basis of Arrhythmias of the European Society of Cardiology: Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J 23: 1648, 2002
2. Kalla H, Yan GX, Marinchak R: Ventricular fibrillation in a patient with prominent J (Osborn) waves and ST segment elevation in the inferior electrocardiographic leads: A Brugada syndrome variant? J Cardiovasc Electrophysiol 1:95, 2000
3. Takagi M, Aihara N, Takaki H, et al: Clinical characteristics of patients with spontaneous or inducible ventricular fibrillation without apparent heart disease presenting with J wave and ST segment elevation in inferior leads. J Cardiovasc Electrophysiol 11:844, 2000
4. Sahara M, Sagara K, Yamashita T, et al: J wave and ST segment elevation in the inferior leads: a latent type of variant Brugada syndrome? Jpn Heart J 43:55, 2002
5. Nakamura W, Segawa K, Ito H, et al: Class Ic antiarrhytmic drugs: Flecainide and pilsicainide, produce segment elevation simulating inferior myocardial ischemia. J Cardiovasc Electrophysiol 9:855, 1998
6. Wichter T, Matheja P, Eckardt L, et al: Cardiac autonomic dysfunction in Brugada syndrome. Circulation 105:702, 2002
7. Hakusui S, Yasuda T, Yanagi T, et al: 123I-MIBG myocardial scintigraphical analysis in patients with and without autonomic disorder. Rinsho Shinkeigaku 34:402, 1994
8. 123I-metaiodobenzylguanidine scintigraphy. Circulation 89:667, 1994
9. Schafers M, Wichter T, Lerch H, et al: Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation. J Nucl Med 40:1-5, 1999
10. Kobayashi H, Ohonish O, Momose M, et al: Characteristic findings of I-123 MIBG scintigraphy in patients with Brugada syndrome. Circulation 96:152, 1997 (suppl, abstr)
11. Agostini D, Scanu P, Loiselet P, et al: Iodine-123metaiodobenzylguanindine SPECT of regional cardiac adrenergic denervation in Brugada syndrome. J Nucl Med 39:1129, 1998
12. Nakamura M, Isobe M, Imamura H: Incessant ventricular fibrillation attacks in a patient with Brugada syndrome. Int J Cardiol 64:205, 1998
13. Nomura M, Nada T, Endo J, et al: Brugada syndrome associated with an autonomic disorder. Heart 80:194, 1998
14. Knickmeier M, Matheja P, Wichter T, et al: Clinical evaluation of no-carrier-added meta-[123I]iodobenzylguanidine for myocardial scintigraphy. Eur J Nucl Med 27:302, 2000
15. Riemann R, Matheja P, Wichter T, et al: Locally reduced cardiac I-123-meta-iodobenzylguanidine (I-12MIBG)uptake in Brugada syndrome. 5th International Conference of Nuclear Cardiology (ICNC5) Viena Austria MAY 2-5, 2001 HOFDURG CENTER
16. Kawasaki T, Kaminaga T, Hirota D, et al: I123metaiodobenzylguanidine myocardial scintigraphy in a patient with brugada syndrome. Clin Nucl Med 26:1058, 2001
17. Haverkamp W, Borggrefe M, Schober O, et al: Cardiac autonomic dysfunction in Brugada syndrome. Circulation 105:702, 2002
18. Oyama N, Oyama N, Yokoshiki H, et al: Iodine-123-metaiodobenzylguanidine scintigraphy of total cardiac adrenergic denervation in Brugada syndrome. Jpn Heart J 43:183, 2002
19. Furuhashi M, Uno K, Tsuchihashi K: Myocardial iodine-123-metaiodobenzylguanidine (123I-MIBG) imaging in Brugada syndrome. Circulation 106:59, 2002
20. Potet F, Mabo P, Le Coq G, et al: Novel brugada SCN5A mutation leading to ST segment elevation in the inferior or the right precordial leads. J Cardiovasc Electrophysiol 14:2000, 2003
21. Takagi M, Aihara N, Kuribayashi S, et al: Localized right ventricular morphological abnormalities detected by electron-beam computed tomography represent arrhythmogenic substrates in patients with the Brugada syndrome. Eur Heart J 22:1032, 2001
22. Vatta M, Dumaine R, Varghese G, et al: Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 11:337, 2002
23. Antzelevitch C: Brugada syndrome: Historical perspectives and observations. Eur Heart J 23:676, 2002
24. Antzelevitch C: Late potentials and the Brugada syndrome. J Am Coll Cardiol 39:1996, 2002
25. Nademanee K, Veerakul G, Nimmannit S, et al: Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 96:2595, 1997